Aquacobalamin


CAS No. : 13422-52-1

13422-52-1
Price and Availability of CAS No. : 13422-52-1
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-113045
M.Wt: 1363.36
Formula: C62H90CoN13O16P
Purity: >98 %
Solubility:
Introduction of 13422-52-1 :

Aquacobalamin is an orally active cobalamin (vitamin B12) derivative. Aquacobalamin acts as an antidote to exert neuroprotective, anticonvulsant, and promyelinating effects. Aquacobalamin exhibits condition-dependent bidirectional redox regulatory functions within cells (antioxidant scavenging of superoxide anions or pro-oxidant induction of cell apoptosis), and possesses weak antitumor activity. Aquacobalamin can be used in research on convulsions, cyanide poisoning, cancer, and hepatitis[1][2][3][4][5][6][7][8]. In Vitro:Aquacobalamin (3.125-200 μg/L; 72 h) exhibits weak cytotoxicity in lung cancer A549 cells and breast cancer BT-474 cells, with IC50 values both >200 nM[7].
Aquacobalamin restores and supports cell proliferation and replication in vitamin B12-deficient L1210 mouse leukemia cells (in combination with Levomefolic acid (HY-14781))[3]. In Vivo:Aquacobalamin (160 μg/kg; i.g.; once daily; 14 days) shows a moderate (10-20%) trend of inhibiting tumor growth in the F1 hybrid mouse model bearing Lewis lung cancer[7].
Aquacobalamin (60 μg/kg; i.m.; once daily; co-administered with Isoniazid for 6 days followed by administration alone for 10 days; 16 days total) normalizes serum total protein levels, reduces lipid peroxidation, and attenuates acute ischemia and cellular degeneration in the renal cortex in the Isoniazid (HY-B0329)-induced acute hepatitis rat model[8].
Aquacobalamin (60 μg/kg; i.m.; once daily; 18 days) prolongs seizure latency, reduces seizure frequency and severity, and exerts antispasmodic, neuroprotective, and myelin-promoting effects in the Thiosemicarbazide (HY-Y0032)-induced epileptic rat model[1].

Your information is safe with us.